Do you want to read an article? Please log in or register.
Palliative Care for Patients With Cancer: ASCO Guideline Update
Further Publications
Related content
Gynecologic Cancer
Neoadjuvant Chemotherapy for Newly Diagnosed, Advanced Ovarian Cancer: ASCO Guideline Update
J Clin Oncol
Gaillard S, Lacchetti C, Armstrong DK, Cliby WA, Edelson MI, Garcia AA, Ghebre RG, Gressel GM, Lesnock JL, Meyer LA, Moore KN, O'Cearbhaill RE, Olawaiye AB, Salani R, Sparacio D, van Driel WJ, Tew WP
doi: 10.1200/JCO-24-02589
Further Publications
Management of Fatigue in Adult Survivors of Cancer: ASCO-Society for Integrative Oncology Guideline Update
J Clin Oncol
Bower JE, Lacchetti C, Alici Y, Barton DL, Bruner D, Canin BE, Escalante CP, Ganz PA, Garland SN, Gupta S, Jim H, Ligibel JA, Loh KP, Peppone L, Tripathy D, Yennu S, Zick S, Mustian K
doi: 10.1200/JCO.24.00541
Further Publications
Selection of Germline Genetic Testing Panels in Patients With Cancer: ASCO Guideline
J Clin Oncol
Tung N, Ricker C, Messersmith H, Balmaña J, Domchek S, Stoffel EM, Almhanna K, Arun B, Chavarri-Guerra Y, Cohen SA, Cragun D, Crew KD, Hall MJ, Idos G, Lopez G, Pal T, Pirzadeh-Miller S, Pritchard C, Rana HQ, Swami U, Vidal GA
doi: 10.1200/JCO.24.00662
Lung, Respiratory and Thoracic Cancer
Palliative care integration and end-of-life care intensity for patients with NSCLC
Lung Cancer
Martin A, Carton M, Thery L, Burnod A, Daniel C, Du Rusquec P, Girard N, Bouleuc C
doi: 10.1016/j.lungcan.2024.107800
Gastrointestinal Cancer
Palliative radiotherapy versus best supportive care in patients with painful hepatic cancer (CCTG HE1): a multicentre, open-label, randomised, controlled, phase 3 study
Lancet Oncol
Dawson LA, Ringash J, Fairchild A, Stos P, Dennis K, Mahmud A, Stuckless TL, Vincent F, Roberge D, Follwell M, Wong RKW, Jonker DJ, Knox JJ, Zimmermann C, Wong P, Barry AS, Gaudet M, Wong RKS, Purdie TG, Tu D, O'Callaghan CJ
doi: 10.1016/S1470-2045(24)00438-8
Genitourinary Cancer
European Association of Urology Guidelines on Non-muscle-invasive Bladder Cancer (TaT1 and Carcinoma In Situ)-A Summary of the 2024 Guidelines Update
Eur Urol
Gontero P, Birtle A, Capoun O, Compérat E, Dominguez-Escrig JL, Liedberg F, Mariappan P, Masson-Lecomte A, Mostafid HA, Pradere B, Rai BP, van Rhijn BWG, Seisen T, Shariat SF, Soria F, Soukup V, Wood R, Xylinas EN
doi: 10.1016/j.eururo.2024.07.027
RECOMMENDED
Breast Cancer
Endocrine and Targeted Therapy for Hormone Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Metastatic Breast Cancer-Capivasertib-Fulvestrant: ASCO Rapid Recommendation Update
★ 2
Recommended by
Prof. Dr Beat Thürlimann, Faculty Member
J Clin Oncol
Burstein HJ, DeMichele A, Fallowfield L, Somerfield MR, Henry NL, Biomarker Testing and Endocrine and Targeted Therapy in Metastatic Breast Cancer Expert Panels, Biomarker Testing and Endocrine and Targeted Therapy in Metastatic Breast Cancer Expert Panels for the Endocrine and Targeted Therapy in Metastatic Breast Cancer Expert Panel
doi: 10.1200/JCO.24.00248
Gastrointestinal Cancer
Phase III randomized trial comparing palliative systemic therapy to best supportive care in advanced esophageal/GEJ cancer
Int J Cancer
Noronha V, Patil VM, Menon N, Goud S, Singh A, Shah M, More S, Shah S, Yadav A, Sonawane S, Nawale K, Chowdhury OR, Kaushal RK, Ghosh-Laskar S, Agarwal JP, Yadav S, Pai T, Janu A, Mahajan A, Purandare N, Banavali S, Badwe R, Prabhash K
doi: 10.1002/ijc.35111
Further Publications
Cannabis and Cannabinoids in Adults With Cancer: ASCO Guideline
J Clin Oncol
Braun IM, Bohlke K, Abrams DI, Anderson H, Balneaves LG, Bar-Sela G, Bowles DW, Chai PR, Damani A, Gupta A, Hallmeyer S, Subbiah IM, Twelves C, Wallace MS, Roeland EJ
doi: 10.1200/JCO.23.02596